Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial

BACKGROUND: Standard treatment of locally advanced rectal cancer (LARC) was neoadjuvant chemoradiotherapy (CRT), followed by total mesorectal excision (TME). Total neoadjuvant treatment (TNT), a new concept, attempts to deliver both systemic chemotherapy and neoadjuvant CRT prior to surgery. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuang, Wang, XiaoZhong, Zhuang, YeZhong, Bai, ShouMin, Wu, XiaoJun, Ye, YiJing, Luo, HuiLong, Yu, HaiNa, Wang, QiaoXuan, Chang, Hui, Zeng, ZhiFan, Cai, PeiQiang, Pan, ZhiZhong, Gao, YuanHong, Chen, Gong, Xiao, WeiWei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315856/
https://www.ncbi.nlm.nih.gov/pubmed/37156624
http://dx.doi.org/10.1002/cam4.6034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315856/
https://www.ncbi.nlm.nih.gov/pubmed/37156624
http://dx.doi.org/10.1002/cam4.6034

Ejemplares similares